GlobeNewswire Inc.··Faruqi & Faruqi, LlpREGENXBIO Investors Face April 14 Deadline in Gene Therapy Securities Lawsuit
REGENXBIO faces securities lawsuit over alleged false statements about gene therapy safety. Investors have until April 14 deadline to join class action after FDA clinical hold.
RGNXstock declinesecurities class action